GeneSwitch gene therapy (UniQure/Leiden University)

N/A

Report date: 2025/03/20 16:01:06

Base Information

Drug NameGeneSwitch gene therapy (UniQure/Leiden University)
Drug Alias NameAAV5-AAT-GeneSwitch-EPO
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAlpha-1-antiproteinase modulators
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniqure Nv
China Registration ClassN/A

Develop Information

Active CompaniesUniqure NvLeiden University Medical Center
Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A